{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:15:42Z","timestamp":1747178142771,"version":"3.40.5"},"reference-count":21,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Addictive Diseases"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/10550887.2021.1987784","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T08:31:07Z","timestamp":1636792267000},"page":"432-438","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["The use of buprenorphine\u2009+\u2009naloxone sublingual tablet in the treatment of neonatal opioid withdrawal syndrome: Two case reports"],"prefix":"10.1080","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-2367","authenticated-orcid":false,"given":"Ersin","family":"Ulu","sequence":"first","affiliation":[{"name":"Neonatology Unit, Department of Pediatrics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-0940","authenticated-orcid":false,"given":"Ali","family":"Kande\u011fer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Selcuk University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-7050","authenticated-orcid":false,"given":"R\u00fcya","family":"Meri\u00e7","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2019.01.009"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029074"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2017-0128"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2015.12.007"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614835"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.5350\/SEMB.20170911063035"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2013.008"},{"key":"CIT0008","unstructured":"Highlights of prescribing information for SUBUTEX\u00ae (buprenorphine sublingual tablets). [accessed 2021 Jul 30]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020732s022lbl.pdf."},{"issue":"3","key":"CIT0009","first-page":"484","volume":"86","year":"1990","journal-title":"Pediatrics"},{"key":"CIT0010","unstructured":"Highlights of prescribing information for NARCAN\u00ae nasal spray. A1135 Issued: 08\/2020. https:\/\/www.narcan.com\/static\/Gen2-Prescribing-Information.pdf."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00058-9"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000637"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443050-00005"},{"key":"CIT0014","unstructured":"Highlights of prescribing information for ssSUBOXONE\u00ae (buprenorphine and naloxone). [accessed 2021 Jul 30]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020733s022lbl.pdf."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3652"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011774"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000640"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.12005.x"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1593993"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(90)90136-3"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.04.006"}],"container-title":["Journal of Addictive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10550887.2021.1987784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:49:02Z","timestamp":1655401742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10550887.2021.1987784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/10550887.2021.1987784"],"URL":"https:\/\/doi.org\/10.1080\/10550887.2021.1987784","relation":{},"ISSN":["1055-0887","1545-0848"],"issn-type":[{"type":"print","value":"1055-0887"},{"type":"electronic","value":"1545-0848"}],"subject":[],"published":{"date-parts":[[2021,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}